Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study | Synapse
September 5, 2022Open Access
Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
Key Points
Key points are not available for this paper at this time.
Abstract
LSD produced long-lasting and notable reductions in anxiety and comorbid depression symptoms up to 16 weeks.